infohep
  • Menu
  • Search
  • Home
  • News
  • About hepatitis
  • Services
  • Countries
  • About us
  • Twitter
  • Facebook
  • RSS
  • Home
  • News
  • All the news

All the news

Showing 10 of 34 articles from: NAFLD

Get an RSS feed of these articles

  • All news
  • infohep news
  • Editors' picks from other sources
  • Novel methods of non-invasive testing for non-alcoholic fatty liver disease

    EASL / 28 August 2020

  • Liver fibrosis assessment in routine care for diabetic patients could uncover a hidden population of people living with advanced liver disease

    EASL / 28 August 2020

  • Two novel treatments show promise in improving biomarkers of NASH pathology

    EASL / 28 August 2020

  • Fatty Liver Disease Tied to Metabolic Health Conditions in People With HIV

    Poz / 24 August 2020

  • Diabetes More Than Doubles Risk of Advanced Liver Disease

    HepMag / 27 July 2020

  • Women Suffer Less NAFLD but More Advanced Fibrosis

    Medscape (requires free registration) / 27 July 2020

  • Global Liver Institute’s International NASH Day Convenes 80 Partner Organizations and 30 Speakers to Declare Urgency of Combatting Parallel Epidemics of Liver Disease and COVID-19

    Global LIver Institute / 15 June 2020

  • 'Another swing, another miss' for Gilead as NASH combo flops in phase 2

    Fierce Biotech / 16 December 2019

  • Gilead Announces Topline Results From Phase 2 ATLAS Study in Patients With Bridging Fibrosis (F3) and Compensated Cirrhosis (F4) Due to Nonalcoholic Steatohepatitis (NASH)

    Gilead press release / 16 December 2019

  • Fatty livers halt tumor-suppressing protein, increasing cancer risk

    Fierce Biotech / 21 October 2019

← First123...4Next →
Other pages in this section
  • Latest news
  • All the news
    • Hepatitis A
    • Hepatitis B
    • Hepatitis C
    • Hepatitis D
    • Hepatitis E
    • Coronavirus
    • NAFLD
      • NASH
      • Experimental treatments for NASH/NAFLD
    • Treatment for hepatocellular carcinoma
    • Transmission, epidemiology and prevention
    • Health services, policy and advocacy
    • Social issues
  • Conference news
  • Noticeboard
  • Email bulletins
  • News feeds

  • Contact us
  • Terms and conditions
  • Accessibility
  • Privacy and cookies

Latest hepatitis news

Sign-up for our monthly email bulletin Follow us on Twitter Find us on Facebook

The information on this website is intended to support, rather than replace, consultation with a healthcare professional.

©NAM Publications 2017. All rights reserved. We are not responsible for the content of external websites.

We are grateful to Abbvie, Janssen, Merck and Gilead for funding infohep.org. Our funders have had no editorial control over the site’s content.

infohep

Latest treatment news and information for patient advocates and people working in hepatitis in Europe.

NAM working with the World Hepatitis Alliance and the European Liver Patients Association

www.infohep.org/page//about-us/Find-out-about-NAM/page/2626330//   www.worldhepatitisalliance.org   www.elpa-info.org